Fairvalue-Calculator Fairvalue-Calculator
EN DE

Stereotaxis, Inc (STXS) Fair Value & Analysis

Healthcare · US · Market cap $183M

Price$1.75
Fair Value$0.8600
Upside-50.9%
Quality95/100
Evidence: Low Range $0.6500 – $1.08

Fair value as of: Jun 24, 2026

Analysis

Stereotaxis, Inc (STXS) currently trades at $1.75, while our model-based Fair Value estimate is $0.8600 — implying the stock looks roughly 50.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to p…

Open the full interactive analysis →

Similar stocks

Intuitive Surgical, Inc (ISRG) -60% EssilorLuxottica Société anonyme (ESLOF) -34% HOYA Corporation (HOCPY) -38% Medline Inc (MDLN) -16% Becton, Dickinson and Company (BDX) -26% Alcon Inc (ALC) -32%

Frequently asked questions

Is Stereotaxis, Inc (STXS) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.8600 versus a price of $1.75 — about −51% (overvalued). Model-based estimate, not financial advice.
What is the fair value of STXS?
Our 21-model fair value for Stereotaxis, Inc is $0.8600 (as of Jun 24, 2026), built from audited fundamentals. The current price is $1.75.
What is the quality score of STXS?
Stereotaxis, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.